Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy by PD-L1 Combined Positive Scores 1-9, 10-19, and >= 20 for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer: KEYNOTE-355 Subgroup Analysis
- Resource Type
- Source
- Subject
- Language
- English